In hepatoma cell lines, the degradation of IRS-1 by HCV core protein translates to impaired ability of insulin to inhibit the expression of the target gene such as insulin growth factor binding protein-1 (IGFBP-1) and may provide a mechanism of insulin resistance and hyperglycemia observed in HCV patients (89). Here, IRS1 is linked to Insulin resistance.